ATP5F1B and obesity disorder: ATP5F1B abundance was increased in SAT samples from insulin-resistant patients with obesity compared to lean insulin-sensitive controls [40], demonstrating an important role in the development of obesity-related IR and inflammation due its involvement in energy and free fatty acid metabolism.